Home › Funds › Lionhunter Capital Management, LLC › RIGL

Lionhunter Capital Management, LLC position in RIGL

RIGEL PHARMACEUTICALS INC · Health Care

Lionhunter Capital Management, LLC reported holding 70,045 shares of RIGL (RIGEL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$3.4M, representing 1.50% of its reported portfolio and ranking #18 among its reported holdings. Lionhunter Capital Management, LLC has disclosed RIGL holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)70.05K sh
Reported value held$3.37M
Portfolio Weight1.50%
First reportedQ2 2026
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Lionhunter Capital Management, LLC's RIGL position evolved

Lionhunter Capital Management, LLC first disclosed a stake in RIGL in Q2 2026 at 63,045 shares (US$2.5M). The position peaked in Q3 2026 at 70,045 shares, worth US$3.4M. Across 2 filings, Lionhunter Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 70,045 shares valued at US$3.4M — an increase of 7,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 63.05K $2.47M New
Q3 2026 70.05K $3.37M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RIGL and 13F data

RIGL (RIGEL PHARMACEUTICALS INC) is a Health Care company. 44 other funds we track also report a position in RIGL — the largest reported positions include Soleus Capital Management, L.P. (US$72.1M), ARMISTICE CAPITAL, LLC (US$65.4M), CM Management, LLC (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RIGL

All RIGL fund holders →

FAQ

How long has Lionhunter Capital Management, LLC held RIGL?

Lionhunter Capital Management, LLC has disclosed RIGL holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Lionhunter Capital Management, LLC's current position in RIGL?

As of Q3 2026, Lionhunter Capital Management, LLC holds 70.05K shares of RIGL (RIGEL PHARMACEUTICALS INC), valued at $3.37M, representing 1.50% of its reported portfolio and ranking #18.

Has Lionhunter Capital Management, LLC been buying or selling RIGL?

In the latest 13F filing (Q3 2026), Lionhunter Capital Management, LLC increased its position in RIGL. The position peaked in Q3 2026 at 70.05K shares.

Which other funds hold RIGL?

Other major institutional holders of RIGL include Soleus Capital Management, L.P., ARMISTICE CAPITAL, LLC, CM Management, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.